It's not that it has to start by that step. As I said, that's a notional, logical sequence of events. All I'm saying is that before the licence could be granted, that would have to happen, and that hasn't happened.
We've already had generic companies approach Health Canada and seek approval for a generic version of a patented drug that they were contemplating exporting under the regime. There's nothing to prevent them from doing that in the absence of a notification to the WTO, but before that can ever crystallize into an actual licence under the regime, that notification has to take place.
I was just saying, notionally, logically, you would think that would be the first step in the process, but it hasn't happened.